Results
Differentially Expressed miRNAs List
| miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
|---|---|---|---|---|---|---|---|---|
| hsa-miR-16-2* | GSE21036 | prostate cancer | prostate cancer | N/A | metastasis | 0.94 | UP | EXP00102 |
| hsa-miR-16-2* | GSE25820 | pancreatic cancer | pancreatic cancer | N/A | cancer vs normal | 0.92 | UP | EXP00136 |
| hsa-miR-16-2* | GSE30454 | colorectal cancer | colorectal cancer | N/A | cancer vs normal | -1.43 | DOWN | EXP00140 |
| hsa-miR-16-2* | GSE31377 | lymphoma | lymphoma | N/A | cancer vs normal | -1.24 | DOWN | EXP00143 |
| hsa-miR-16-2* | GSE31629 | leukemia | leukemia | N/A | cancer vs normal | 0.71 | UP | EXP00149 |
| hsa-miR-16-2* | GSE31045 | sarcoma | sarcoma | N/A | cancer vs normal | -2.10 | DOWN | EXP00157 |
| hsa-miR-16-2* | GSE32960 | nasopharyngeal cancer | nasopharyngeal cancer | N/A | cancer vs normal | -0.43 | DOWN | EXP00170 |
| hsa-miR-16-2* | GSE36681 | lung cancer | lung cancer | N/A | cancer vs normal | 0.33 | UP | EXP00176 |
| hsa-miR-16-2* | GSE28423 | sarcoma | sarcoma | N/A | cancer vs normal | 1.97 | UP | EXP00189 |
| hsa-miR-16-2* | GSE40525 | breast cancer | breast cancer | N/A | cancer vs normal | 0.67 | UP | EXP00191 |
| hsa-miR-16-2* | GSE45264 | lymphoma | lymphoma | N/A | cancer vs normal | -3.36 | DOWN | EXP00216 |
| hsa-miR-16-2* | GSE36915 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | 0.64 | UP | EXP00221 |
| hsa-miR-16-2* | GSE40345 | mesothelioma | mesothelioma | N/A | cancer vs normal | 1.32 | UP | EXP00234 |
| hsa-miR-16-2* | GSE45666 | breast cancer | breast cancer | N/A | cancer vs normal | 0.41 | UP | EXP00236 |
| hsa-miR-16-2* | GSE45666 | breast cancer | breast cancer | N/A | cancer vs normal | 0.48 | UP | EXP00238 |